These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. Platt JL; Zhou X; Lefferts AR; Cascalho M Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420051 [TBL] [Abstract][Full Text] [Related]
26. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer. Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532 [TBL] [Abstract][Full Text] [Related]
27. Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation. Smorodinsky-Atias K; Goshen-Lago T; Goldberg-Carp A; Melamed D; Shir A; Mooshayef N; Beenstock J; Karamansha Y; Darlyuk-Saadon I; Livnah O; Ahn NG; Admon A; Engelberg D Mol Biol Cell; 2016 Mar; 27(6):1026-39. PubMed ID: 26658610 [TBL] [Abstract][Full Text] [Related]
28. ERK1/2 can feedback-regulate cellular MEK1/2 levels. Hong SK; Wu PK; Karkhanis M; Park JI Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823 [TBL] [Abstract][Full Text] [Related]
29. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Rao CV; Sanghera S; Zhang Y; Biddick L; Reddy A; Lightfoot S; Dai W; Yamada HY Mol Carcinog; 2016 May; 55(5):600-10. PubMed ID: 25773652 [TBL] [Abstract][Full Text] [Related]
30. Active ERK2 is sufficient to mediate growth arrest and differentiation signaling. Wu PK; Hong SK; Yoon SH; Park JI FEBS J; 2015 Mar; 282(6):1017-30. PubMed ID: 25639353 [TBL] [Abstract][Full Text] [Related]
31. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
32. Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Park JI Front Biol (Beijing); 2014 Feb; 9(2):95-103. PubMed ID: 24999356 [TBL] [Abstract][Full Text] [Related]
33. The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. Guégan JP; Frémin C; Baffet G Int J Hepatol; 2012; 2012():328372. PubMed ID: 23133759 [TBL] [Abstract][Full Text] [Related]
34. MEK genomics in development and disease. Bromberg-White JL; Andersen NJ; Duesbery NS Brief Funct Genomics; 2012 Jul; 11(4):300-10. PubMed ID: 22753777 [TBL] [Abstract][Full Text] [Related]
35. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. Lee CS; Dykema KJ; Hawkins DM; Cherba DM; Webb CP; Furge KA; Duesbery NS PLoS One; 2011 Feb; 6(2):e17165. PubMed ID: 21365009 [TBL] [Abstract][Full Text] [Related]
36. Effects of bevacizumab in mouse model of endometrial cancer: Defining the molecular basis for resistance. Davies S; Dai D; Pickett G; Thiel KW; Korovkina VP; Leslie KK Oncol Rep; 2011 Mar; 25(3):855-62. PubMed ID: 21240464 [TBL] [Abstract][Full Text] [Related]
37. The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. Langlois MJ; Bergeron S; Bernatchez G; Boudreau F; Saucier C; Perreault N; Carrier JC; Rivard N PLoS One; 2010 Dec; 5(12):e15742. PubMed ID: 21203412 [TBL] [Abstract][Full Text] [Related]
38. The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Bergeron S; Lemieux E; Durand V; Cagnol S; Carrier JC; Lussier JG; Boucher MJ; Rivard N Mol Cancer; 2010 Oct; 9():271. PubMed ID: 20942929 [TBL] [Abstract][Full Text] [Related]
39. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Voisin L; Saba-El-Leil MK; Julien C; Frémin C; Meloche S Mol Cell Biol; 2010 Jun; 30(12):2918-32. PubMed ID: 20368360 [TBL] [Abstract][Full Text] [Related]